Pharmaceutical industry
BioNTech Commits to Eradicating Malaria with mRNA Vaccine Technology
German biotech company BioNTech SE has announced a project to develop a malaria vaccine candidate using its proprietary mRNA technology, backed by the eradicateMalaria initiative. This ambitious goal aims to expand vaccine production capacity across Africa and follows a two-pronged approach: developing a first-generation vaccine using a known antigen and